Routine cGMP inspection found three observations at a Strides Pharma Science Limited manufacturing facility in Chennai.
1 report, 1 independent
Updated Sep 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Routine cGMP inspection found three observations at a Strides Pharma Science Limited manufacturing facility in Chennai.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United States Food and Drug Administration
agency of the US Department of Health and Human Services
Related events
- The US Food and Drug Administration conducted a routine cGMP inspection of a facility belonging to OneSource Specialty Pharma Limited.
- The US Food and Drug Administration conducted a cGMP inspection at a facility belonging to Cipla.
- A routine inspection of a GMP manufacturing unit in Visakhapatnam, Andhra Pradesh, was conducted by the United States Food and Drug Administration and confirmed regulatory compliance.